Supernus Pharmaceuticals Files Form 4 with SEC
UKPulse Money Desk
Supernus Pharmaceuticals Inc has submitted a Form 4 filing to the SEC, dated 31 July. The filing was reported by Investing.com UK on 1 August 2026.
- Supernus Pharmaceuticals Inc filed a Form 4 with the SEC for 31 July.
- The filing was reported on 1 August 2026.
Supernus Pharmaceuticals Inc has lodged a Form 4 filing with the US Securities and Exchange Commission, dated 31 July. The filing was noted by Investing.com UK on Saturday 1 August 2026.
Form 4 is typically used to report changes in the holdings of company insiders. No further details of the filing were disclosed.